Business Wire

Business Wire

Evobrutinib, CNS-Penetrant BTKi, Has Shown Sustained Clinical Benefit Up to Five Years in People with RMS

Data from the ongoing Phase II open-label extension (OLE) study of evobrutinib show sustained clinical efficacy and a safety profile that remains consistent with that previously reported over five years of therapy - the longest follow-up of any Bruton’s...
Business Wire

Bristol Myers Squibb Presents New Zeposia (ozanimod) Data on Long-Term Disease Progression and Cognition in Patients with Relapsing Forms of Multiple Sclerosis

Late-breaking data from the DAYBREAK and RADIANCE trials show similarly low rates of progression independent relapse activity (PIRA) and relapse-associated worsening (RAW) after eight years of follow-up First interim readout from Phase 3b ENLIGHTEN trial shows almost half of patients...
Business Wire

Kosmos Energy Announces Oil Discovery in the U.S. Gulf of Mexico

DALLAS--(BUSINESS WIRE)--Kosmos Energy (NYSE/LSE: KOS) announced today an oil discovery in the U.S. Gulf of Mexico at the Tiberius exploration well. Kosmos is operator of the well and has a 33.34% working interest alongside Occidental and Equinor ASA (both...
Business Wire

Genentech’s Ocrevus Twice-Yearly, 10-Minute Subcutaneous Injection Was Non-Inferior to Intravenous Infusion and Provided Near-Complete Suppression of Brain Lesions

– Late-breaking Phase III results show subcutaneous injection was non-inferior to intravenous infusion based on Ocrevus levels in the blood over 12 weeks – – Ocrevus subcutaneous injection was comparable to IV infusion in providing rapid and sustained depletion of...
Business Wire

Octave® Bioscience, Inc. Presents Data Highlighting Application and Impact of its Precision Care Solution at MSMilan2023

Nine posters demonstrate deep insights provided by company’s Multiple Sclerosis Disease Activity Test and enhanced MRI analytics and protocolsMENLO PARK, Calif.--(BUSINESS WIRE)--Octave® Bioscience, Inc., a leading precision care company that delivers a new standard for managing multiple sclerosis (MS)...
Business Wire

Centrient Pharmaceuticals joins Almirall’s growing innovation hub in Barcelona

This agreement represents a strategic step in innovation for Centrient. It will catalyse the expansion and diversification of their product portfolio while driving the development of sustainable and efficient manufacturing processes for its esteemed range of products Almirall reinforces its...
Business Wire

EMD Serono Presents New MAVENCLAD® (Cladribine) Tablets Data Highlighting Sustained Reduction in NfLs and Benefit of Early Initiation

New data showed sustained reduction in neurofilament light chain (NfL) levels over two years of treatment with MAVENCLAD® (cladribine) tablets in patients with relapsing multiple sclerosis (RMS) Findings from real-world evidence (RWE) studies suggest a shift toward the use of...
Business Wire

Merck Presents New MAVENCLAD® (Cladribine Tablets) Data Highlighting Sustained Reduction in NfLs and Benefit of Early Initiation

New data showed sustained reduction in neurofilament light chain (NfL) levels over two years of treatment with MAVENCLAD® (cladribine tablets) in patients with relapsing multiple sclerosis (RMS) Findings from real-world evidence (RWE) studies suggest a shift toward the use of...
Business Wire

Genentech’s Vabysmo Maintained Vision Improvements With Extended Treatment Intervals Up to Four Months for People With Retinal Vein Occlusion (RVO) in Phase III Trials

– Vabysmo showed robust and sustained retinal drying up to 72 weeks and a safety profile consistent with previous trials – – If approved by the FDA, RVO would be Vabysmo’s third indication in addition to wet age-related macular degeneration...
Business Wire

Adenia Announces First Investment for Fifth Flagship Fund

Adenia has acquired a majority stake in Enfin, a provider of solar funding solutions in South Africa.JOHANNESBURG--(BUSINESS WIRE)--Adenia Partners (“Adenia”), a private markets investment firm committed to responsible investing and a sustainable Africa, has completed a majority investment in...
1...100101102...203Page 101 of 203

Latest News

NewsOilNOW -

Hess reports Q3 gains with Guyana leading production growth

Hess Corporation revealed a strong third quarter driven by expanded production in Guyana’s offshore Stabroek Block. The company reported...

OilNOW is a Resource Center founded and owned by Guyanese. OilNOW is an apolitical, non-partisan, privately owned agency that strives to ensure the highest degree of accuracy and balance.

Quick Access

Company Info

Social Networks